[1] |
Li M, Hou WS, Zhang XW, et al. Hyperuricemia and risk of stroke: a systematic review and meta-analysis of prospective studies. Atherosclerosis, 2014; 232, 265−70. doi: 10.1016/j.atherosclerosis.2013.11.051 |
[2] |
Vogt B. Urate oxidase (rasburicase) for treatment of severe tophaceous gout. Nephrol Dial Transplant, 2005; 20, 431−3. doi: 10.1093/ndt/gfh629 |
[3] |
Wang YG, Yan SL, Li CG, et al. Risk factors for gout developed from hyperuricemia in China: a five-year prospective cohort study. Rheumatol Int, 2013; 33, 705−10. doi: 10.1007/s00296-012-2439-8 |
[4] |
Liu R, Han C, Wu D, et al. Prevalence of hyperuricemia and gout in Mainland China from 2000 to 2014: A systematic review and meta-analysis. Biomed Res Int, 2015; 2015, 762820. |
[5] |
Bezerra TTD, Bezerra LS, Santos-Veloso MAO, et al. Association between hyperuricemia and hypertension: a case-control study. Rev Assoc Med Bras (1992), 2021; 67, 828−32. doi: 10.1590/1806-9282.20210021 |
[6] |
Shirasawa T, Ochiai H, Yoshimoto T, et al. Correction to: Cross-sectional study of associations between normal body weight with central obesity and hyperuricemia in Japan. BMC Endocr Disord, 2020; 20, 26. doi: 10.1186/s12902-020-0494-9 |
[7] |
Lu XX, Shi XG, Li YB, et al. A negative association between urinary iodine concentration and the prevalence of hyperuricemia and gout: a cross-sectional and population-based study in Mainland China. Eur J Nutr, 2020; 59, 3659−68. doi: 10.1007/s00394-020-02199-z |
[8] |
Sun P, Chen MQ, Guo XF, et al. Combined effect of hypertension and hyperuricemia on ischemic stroke in a rural Chinese population. BMC Public Health, 2021; 21, 776. doi: 10.1186/s12889-021-10858-x |
[9] |
Ali N, Miah R, Hasan M, et al. Association between serum uric acid and metabolic syndrome: a cross-sectional study in Bangladeshi adults. Sci Rep, 2020; 10, 7841. doi: 10.1038/s41598-020-64884-7 |
[10] |
Saito Y, Tanaka A, Node K, et al. Uric acid and cardiovascular disease: A clinical review. J Cardiol, 2021; 78, 51−7. doi: 10.1016/j.jjcc.2020.12.013 |
[11] |
Ae R, Kanbay M, Kuwabara M. The causality between the serum uric acid level and stroke. Hypertens Res, 2020; 43, 354−6. doi: 10.1038/s41440-019-0346-z |
[12] |
Song PG, Wang H, Xia W, et al. Prevalence and correlates of hyperuricemia in the middle-aged and older adults in China. Sci Rep, 2018; 8, 4314. doi: 10.1038/s41598-018-22570-9 |
[13] |
Ito S, Torii T, Nakajima A, et al. Prevalence of gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database. BMC Pediatr, 2020; 20, 481. doi: 10.1186/s12887-020-02379-0 |
[14] |
Arersa KK, Wondimnew T, Welde M, et al. Prevalence and determinants of hyperuricemia in type 2 diabetes mellitus patients attending Jimma Medical Center, Southwestern Ethiopia, 2019. Diabetes Metab Syndr Obes, 2020; 13, 2059−67. doi: 10.2147/DMSO.S252825 |
[15] |
Lee JH. Prevalence of hyperuricemia and its association with metabolic syndrome and cardiometabolic risk factors in Korean children and adolescents: analysis based on the 2016-2017 Korea National Health and Nutrition Examination Survey. Korean J Pediatr, 2019; 62, 317−23. doi: 10.3345/kjp.2019.00444 |
[16] |
Billa G, Dargad R, Mehta A. Prevalence of hyperuricemia in Indian subjects attending hyperuricemia screening programs-A retrospective study. J Assoc Physicians India, 2018; 66, 43−6. |
[17] |
Zhu YY, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum, 2011; 63, 3136−41. doi: 10.1002/art.30520 |
[18] |
Kim SK, Choe JY. Association between smoking and serum uric acid in Korean population. Medicine (Baltimore), 2019; 98, e14507. doi: 10.1097/MD.0000000000014507 |
[19] |
Nejatinamini S, Ataie-Jafari A, Qorbani M, et al. Association between serum uric acid level and metabolic syndrome components. J Diabetes Metab Disord, 2015; 14, 70. doi: 10.1186/s40200-015-0200-z |
[20] |
Guan SC, Tang Z, Fang XH, et al. Prevalence of hyperuricemia among Beijing post-menopausal women in 10 years. Arch Gerontol Geriatr, 2016; 64, 162−6. doi: 10.1016/j.archger.2016.02.002 |
[21] |
Huang XB, Zhang WQ, Tang WW, et al. Prevalence and associated factors of hyperuricemia among urban adults aged 35-79 years in southwestern China: a community-based cross-sectional study. Sci Rep, 2020; 10, 15683. doi: 10.1038/s41598-020-72780-3 |
[22] |
Liu B, Wang T, Zhao HN, et al. The prevalence of hyperuricemia in China: a meta-analysis. BMC Public Health, 2011; 11, 832. doi: 10.1186/1471-2458-11-832 |
[23] |
Yu DM, Zhao LY, Zhang J, et al. China nutrition and health surveys (1982-2017). China CDC Wkly, 2021; 3, 193−5. doi: 10.46234/ccdcw2021.058 |
[24] |
Su P, Hong L, Zhao YF, et al. Relationship between hyperuricemia and cardiovascular disease risk factors in a Chinese population: A cross-sectional study. Med Sci Monit, 2015; 21, 2707−17. doi: 10.12659/MSM.895448 |
[25] |
Ali N, Perveen R, Rahman S, et al. Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: A study on Bangladeshi adults. PLoS One, 2018; 13, e0206850. doi: 10.1371/journal.pone.0206850 |
[26] |
Liu H, Zhang XM, Wang YL, et al. Prevalence of hyperuricemia among Chinese adults: a national cross-sectional survey using multistage, stratified sampling. J Nephrol, 2014; 27, 653−8. doi: 10.1007/s40620-014-0082-z |
[27] |
Maloberti A, Qualliu E, Occhi L, et al. Hyperuricemia prevalence in healthy subjects and its relationship with cardiovascular target organ damage. Nutr Metab Cardiovasc Dis, 2021; 31, 178−85. doi: 10.1016/j.numecd.2020.08.015 |
[28] |
Sari I, Akar S, Pakoz B, et al. Hyperuricemia and its related factors in an urban population, Izmir, Turkey. Rheumatol Int, 2009; 29, 869−74. doi: 10.1007/s00296-008-0806-2 |
[29] |
Yu SS, Yang HM, Guo XF, et al. Prevalence of hyperuricemia and its correlates in rural Northeast Chinese population: from lifestyle risk factors to metabolic comorbidities. Clin Rheumatol, 2016; 35, 1207−15. doi: 10.1007/s10067-015-3051-6 |
[30] |
Lohsoonthorn V, Dhanamun B, Williams MA. Prevalence of hyperuricemia and its relationship with metabolic syndrome in Thai adults receiving annual health exams. Arch Med Res, 2006; 37, 883−9. doi: 10.1016/j.arcmed.2006.03.008 |
[31] |
Hak AE, Choi HK. Menopause, postmenopausal hormone use and serum uric acid levels in US women – The Third National Health and Nutrition Examination Survey. Arthritis Res Ther, 2008; 10, R116. doi: 10.1186/ar2519 |
[32] |
De Vera MA, Rahman MM, Bhole V, et al. Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study. Ann Rheum Dis, 2010; 69, 1162−4. doi: 10.1136/ard.2009.122770 |
[33] |
Roddy E, Zhang WY, Doherty M. The changing epidemiology of gout. Nat Clin Pract Rheumatol, 2007; 3, 443−9. |
[34] |
Cho SK, Winkler CA, Lee SJ, et al. The prevalence of hyperuricemia sharply increases from the late menopausal transition stage in middle-aged women. J Clin Med, 2019; 8, 296. doi: 10.3390/jcm8030296 |
[35] |
Gerber V, Goldbourt U, Drory Y, et al. Interaction between income and education in predicting long-term survival after acute myocardial infarction. Eur J Cardiovasc Prev Rehabil, 2008; 15, 526−32. doi: 10.1097/HJR.0b013e328304feac |
[36] |
Zhang LX, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet, 2012; 379, 815−22. doi: 10.1016/S0140-6736(12)60033-6 |
[37] |
Zuo H, Shi ZM, Hu XS, et al. Prevalence of metabolic syndrome and factors associated with its components in Chinese adults. Metabolism, 2009; 58, 1102−8. doi: 10.1016/j.metabol.2009.04.008 |
[38] |
Popkin BM, Du SF, Zhai FY, et al. Cohort Profile: The China Health and Nutrition Survey-monitoring and understanding socio-economic and health change in China, 1989-2011. Int J Epidemiol, 2010; 39, 1435−40. doi: 10.1093/ije/dyp322 |
[39] |
Choi HK, Atkinson K, Karlson EW, et al. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med, 2004; 350, 1093−103. doi: 10.1056/NEJMoa035700 |
[40] |
Winder M, Owczarek AJ, Mossakowska M, et al. Prevalence of hyperuricemia and the use of allopurinol in older poles-results from a population-based PolSenior study. Int J Environ Res Public Health, 2021; 18, 387. doi: 10.3390/ijerph18020387 |
[41] |
Yang BY, Mo ZN, Wu C, et al. A genome-wide association study identifies common variants influencing serum uric acid concentrations in a Chinese population. BMC Med Genomics, 2014; 7, 10. doi: 10.1186/1755-8794-7-10 |